QuickView for protein kinase A catalytic subunit binding (biogroup)

1. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
2. L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens
3. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
4. L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
5. L1000 CMAP - Breast adenocarcinoma SKBR3 cells treated with small molecule perturbagens

There were no matches for protein kinase A catalytic subunit binding

1. TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanc…
2. MK2206 in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer
3. Chinese Herbal Formulation PHY906 and Sorafenib Tosylate in Treating Patients With Advanced Liver Ca…
4. Temsirolimus With or Without Megestrol Acetate and Tamoxifen Citrate in Treating Patients With Advan…
5. PIK3CA/PTEN-altered Advanced Breast Cancer Treated With MEN1611 Monotherapy or in Combination With E…